Beloranib Beloranib is an analogue of the natural chemical compound fumagillin and is a methionine aminopeptidase 2 (MetAP2) inhibitor acting to reduce production of new fatty acid molecules by the liver and converting stored fats into useful energy (233)
AOD 9604/MOTs-C (Fat Burner) Benefits of MOTs-C (Cell Optimization & Metabolic Health) Benefits of MOTs-C (Cell Optimization & Metabolic Health) Boosts Mitochondrial Function: Improves energy production at the cellular level
If deficiency is confirmed, treatment is typically clinician-supervised and intramuscular
The standard regimen involves: Loading doses without neurological involvement : 1 mg intramuscularly three times a week for 2 weeks [3] [8] Loading doses with neurological involvement : 1 mg intramuscularly on alternate days until no further improvement [3] [8] Maintenance therapy : 1 mg every 23 months for life in cases of pernicious anaemia or irreversible malabsorption (every 2 months if neurological involvement) [3] [8] This aggressive approach aims to prevent irreversible neurological damage, though recovery of established neuropathy may be incomplete, particularly if treatment is delayed
The most commonly reported side effects include: Pain, bruising, or redness at the injection site Mild nausea or stomach upset Diarrhea Headache Allergic reaction (rare) Because MIC injections are compounded formulations, the quality and composition can differ from one clinic to another
